Sanofi: Stop the Bleeding with Bioverativ

Healthcare Specialist

Winnie Wong

Equity Bottom-Up

<p>The Securities and Exchange Commission (SEC) believes that insider trading occurred around <a href="https://www.smartkarma.com/entities/4564" target="_blank" data-smartkarma-citation="entities:4564:1">Sanofi (SAN FP)</a> 's $11.6 billion deal for <a href="https://www.smartkarma.com/entities/26434" target="_blank" data-smartkarma-citation="entities:26434:1">Bioverativ Inc (BIVV US)</a> .  Last Friday, <a href="https://www.sec.gov/litigation/litreleases/2018/lr24035.htm" target="_blank">SEC filed a lawsuit</a> in the US District Court for the Southern District of New York against “unknown traders” who made “a series of suspicious transactions” surrounding the announcement of a definitive agreement under which Sanofi will acquire Bioverativ".</p><p>The regulator believes that the traders allegedly used foreign broker…</p>

The Securities and Exchange Commission (SEC) believes that insider trading occurred around Sanofi (SAN FP) 's $11.6 billion deal for Bioverativ Inc (BIVV US) .  Last Friday, SEC filed a lawsuit in the US District Court for the Southern District of New York against “unknown traders” who made “a series of suspicious transactions” surrounding the announcement of a definitive agreement under which Sanofi will acquire Bioverativ".The regulator believes that the traders allegedly used foreign broker…

Insider Trading Alleged as Sanofi Continues Its Shopping Spree